Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery
ClinicalTrials.gov NCT04689048
Research payments
$97,597
Through program year 2025, $97,597 in research payments was reported against Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery, across 18 payments, paid by Blue Earth Diagnostics Limited.
- Paid by
- Blue Earth Diagnostics Limited
- ClinicalTrials.gov
- NCT04689048
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $10,333 | 2 |
| 2024 | Research | $29,664 | 6 |
| 2023 | Research | $57,600 | 10 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.